enzastaurin has been researched along with 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione in 1 studies
| Studies (enzastaurin) | Trials (enzastaurin) | Recent Studies (post-2010) (enzastaurin) | Studies (4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione) | Trials (4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione) | Recent Studies (post-2010) (4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione) |
|---|---|---|---|---|---|
| 188 | 52 | 99 | 126 | 1 | 84 |
| Protein | Taxonomy | enzastaurin (IC50) | 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (IC50) |
|---|---|---|---|
| [tau protein] kinase | Oryctolagus cuniculus (rabbit) | 2 | |
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 10 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 10 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 2.15 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 1.145 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 10 | |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 4.5 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 2.0608 | |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biru, T; Cinatl, J; Doerr, HW; Loeschmann, N; Michaelis, M; Ogbomo, H | 1 |
1 other study(ies) available for enzastaurin and 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione
| Article | Year |
|---|---|
The anti-tumoral drug enzastaurin inhibits natural killer cell cytotoxicity via activation of glycogen synthase kinase-3β.
Topics: Antineoplastic Agents; Cell Line; Dose-Response Relationship, Drug; Enzyme Activation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Killer Cells, Natural; Perforin; Phosphorylation; Thiadiazoles | 2011 |